Held at different venues in Mumbai, MMRDA Grounds, BKC and BEC, Goregaon, the twin events reportedly saw attendance from 1,500+ exhibitors and participation from 40+ countries
The 11th edition of the signature event, CPhI & P-MEC India 2017, leading pharma networking expos, were held recently at two venues in Mumbai, i.e. MMRDA Grounds, Bandra Kurla Complex and Bombay Exhibition Centre, Goregaon.
This year’s event reportedly had more than 1,500+ exhibitors, and 40+ countries’ participation. The key companies who exhibited in the 2017 edition at CPhI were
Aurobindo Pharma, Granules India, Hetero Labs, Signet Chemical Corporation, DKSH India, Morepen Laboratories, NV Organics amongst others. On the other hand, some of the leading companies such as West Pharmaceuticals Packaging India, Cadmach Machinery, Brothers Pharmamach (I), NPM Machinery, Jekson Vision, ACG Worldwide Solid Dosage Consumables and Machinery, Ace Technologies & Packaging Systems, Fabtech Technologies International, Jagson
Engineers, Bosch, Agilent, Food & Pharma Specialities amongst others exhibited
at P-MEC.
The inauguration of CPhI and P-MEC 2017 occurred at MMRDA Grounds, Bandra Kurla Complex in the presence of industry leaders including Satish Wagh,
Chairman, Chemexcil; Rahul Deshpande, Group Director, UBM India; Jime Essink, CEO, UBM Asia; Aasif Khan, Director, Fabtech Technologies; Rajendra Khimsaria,
Director, Khimsaria Associates; Khaja Nizamuddin, Director, Pharmapack Packaging Equipment; Yogesh Mudras, MD, UBM India and other key dignitaries.
Yogesh Mudras, MD, UBM India said, “India is among the fastest-growing pharma markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the industry a definite competitive advantage over other countries. A platform like CPhI and P-MEC India provides a most comprehensive industry platform for every company that deals with pharmaceuticals in India. CPhI and P-MEC India is widely used as a barometer of pharma’s overall health in India. Being the only platform that brings together Indian and global companies, the mammoth expo is a strong event reflecting and enhancing the value of the prosperous pharma industry.”
Alongside the expo, UBM India also launched the second edition of the India Pharma Week (IPW), an attractive platter of over ten trend-setting events.
Some of the key highlights of India Pharma Week were:
Pre-connect Congress
The 3rd Pre-Connect Congress 2017, was a forum that saw a congregation of renowned leaders who have headed large pharma organisations and propelled them to reach new heights of success. The forum provided a unique opportunity to all key stakeholders in the pharma industry to assemble on a single platform and discuss, deliberate as well as share their thoughts on achieving the next phase of growth.
Women in Pharma
‘Women in Pharma: Aspire, Lead, Inspire’, was one of the other highlights of India Pharma Week 2017 saw a congregation of women leaders in senior-management
levels, entrepreneurs, and mentors from the pharma and bio-pharma industry to celebrate the significant contribution of women in this industry and share their
inspiring stories, experiences and knowledge. The second edition of ‘Women in Pharma’ involved senior male leaders from the industry as well.
Some of the professionals who were a part of the interaction included Sindhushree Khullar, former CEO, NITI Aayog, Former Secretary-Planning Commission,
Government of India; Savindu Kudrigikar, Business Head (South Asia), Pharma, Food and Medical, Dow Chemical International; Aparna Thomas, Senior Director – Communications & CSR (India & South Asia), Sanofi; Deepshikha Mukerji, Regional Human Resources Director, Established Pharmaceuticals, Abbott; Pratima Reddy, Director – R&D Portfolio, Governance and Strategy Merck Consumer Health (CH), Merck; Rajiv Oza, HRBL – Global Manufacturing & Supply (GMS) , South Asia, GlaxoSmithKline Pharmaceuticals; Dr Sofia Mumtaz, President-Portfolio and Legal, Lupin; Ameera Shah, Promoter & MD, Metropolis Healthcare; and Kanchana TK, Director General, OPPI along with an inspirational talk by Vasu Primlani, corporate trainer and stand-up comedian.
CEO Roundtable
One of its most significant events, the CEO Roundtable, was a congregation of
India’s most influential CEOs, Presidents & Founders from leading pharma companies, and policy makers and senior representatives from pharma associations. They engaged with one another on the vital issue of Make in India – ensuring India’s pharma supremacy with a special focus on affordable healthcare in the urban and rural areas in India. The industry professionals who were a part of the
exclusive meeting included DG Shah, Secretary General, Indian Pharmaceutical
Alliance (IPA); Dr Dinesh Dua, CEO & Director, Nector Lifesciences; SV Veeramani, Chairman & MD, Fourrts (India) Laboratories; Prashant Nagre, CEO,
Fermenta Biotach; Ranga Iyer, Former MD, Wyeth; Rajiv Gulati, Former President, Ranbaxy; Suresh Subramanium, Senior VP & Head, Branded Formulations, South Asia; Ashok Bhattacharya, Executive Director/Country Manager, Takeda Pharmaceuticals India; Prof Pierre Pienaar, President, WPO; Dev Prakash Yadava, MD, Shardachem; Dr GM Warke, Founder & CMD, HiMedia Laboratories; A Vaidheesh, MD, GSK; Ziva Abraham, CEO, Microrite Inc; Srinivas Lanka, Vice Chairman Pharma and Bio Taskforce, Andhra Pradesh Economic Development Board; Kewal Handa, Director, Salus Lifesciences; BG Barve, Joint MD, Bluecross Laboratories; SM Mudda, Director Global Strategy, Microlabs and Mudras.
A representative body of the group comprising Handa, Dr Dua, Sriram Shrinivasan, Partner, Ernst & Young LLP, Mudda and Mudras later interacted with the media to discuss the key tenets of its proposals.
Focusing on the pillars of business, knowledge, leadership, innovation, recognition and networking in the pharma domain, the IPW also included a plant visit, Pharma Leaders’ Golf, the India Pharma Awards, networking evening, and many more activities.
CPhI 2017 was well appreciated by all the stakeholders of the pharma industry.
- Advertisement -
Comments are closed.